ROSIGLITAZONE, AN AGONIST OF PEROXISOME-PROLIFERATOR ACTIVATED RECEPTOR-GAMMA, AMELIORATES CISPLATIN NEPHROTOXICITY THROUGH THE INHIBITION OF TNF-α/NF-κB ACTIVATION

被引：0
|
作者：
Park, Sung-Kwang [1 ]
Lee, Sik [1 ]
Kim, Won [1 ]
Moon, Sang-Ok [1 ]
Sung, Mi Jeong [1 ]
Kim, Duk Hoon [1 ]
Kang, Kyung Pyo [1 ]
Kang, Sung Kyew [1 ]
机构：
[1] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Renal Regenerat Lab,Res Inst Clin Med, Chonju, South Korea
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A278 / A278
页数：1
相关论文
共 50 条
  • [31] Activation of peroxisome proliferator-activated receptor gamma (PPAR-g) ameliorates functional and tissue damages attributed to chronic cyclosporine nephrotoxicity.
    Pereira, MG
    Camara, NOS
    Cenedeze, MA
    Campanholle, G
    Teixeira, VPA
    Reis, MA
    Pacheco-Silva, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 442 - 442
  • [32] Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma through suppression of NF-kB in HT-29 cell
    Lee, SK
    Kim, HJ
    Chi, SG
    Jang, JY
    Nam, KD
    Kim, NH
    Joo, KR
    Dong, SH
    Kim, BH
    Chang, YW
    Lee, JI
    Chang, R
    GASTROENTEROLOGY, 2005, 128 (04) : A619 - A619
  • [33] Telmisartan inhibits cytokine-induced nuclear factor-kappa B activation independently of the peroxisome proliferator-activated receptor-gamma
    Nakano, Ayuko
    Hattori, Yoshiyuki
    Aoki, Chie
    Tomizawa, Atsuko
    Jojima, Teruo
    Kawagoe, Yoshiaki
    Kase, Hiroyuki
    Kasai, Kikuo
    ENDOCRINE JOURNAL, 2010, 57 : S554 - S554
  • [34] The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients
    Sidhu, JS
    Cowan, D
    Kaski, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (10) : 1757 - 1763
  • [35] Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-B activation in patients with hepatocellular carcinoma
    Nojima, Hiroyuki
    Kuboki, Satoshi
    Shinoda, Kimio
    Shimizu, Hiroaki
    Ohtsuka, Masayuki
    Kato, Atsushi
    Yoshitomi, Hideyuki
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Miyazaki, Masaru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2016, 23 (09) : 574 - 584
  • [36] Danshensu attenuates cisplatin-induced nephrotoxicity through activation of Nrf2 pathway and inhibition of NF-κB
    Yu, Chen
    Dong, Hua
    Wang, Qingchen
    Bai, Junzhe
    Li, Yan-Ni
    Zhao, Juan-Juan
    Li, Jia-Zhu
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [37] THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONIST ROSIGLITAZONE ATTENUATES ADVANCED GLYCATION END PRODUCTS INDUCED ENDOTHELIAL PROGENITOR CELLS DYSFUNCTION VIA AKT/ENOS SIGNAL PATHWAY
    Liang, C.
    Wu, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [38] Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces but does not prevent, the pulmonary CD4+ effector T-cell response in a murine model of asthma
    Maslanka, Tomasz
    Otrocka-Domagala, Iwona
    Zuska-Prot, Monika
    Gesek, Michal
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [39] Inhibition of NF-κB signaling by fenofibrate, a peroxisome proliferator-activated receptor-α ligand, presents a therapeutic strategy for rheumatoid arthritis
    Okamoto, H
    Iwamoto, T
    Kotake, S
    Momohara, S
    Yamanaka, H
    Kamatani, N
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (03) : 323 - 330
  • [40] Peroxisome proliferator-activated receptor-alpha (PPARα) activators inhibit NF-κB activation in human monocytic cells.
    Marx, N
    Mackman, N
    Uwe, S
    Yilmaz, N
    Hombach, V
    Plutzky, J
    CIRCULATION, 2000, 102 (18) : 104 - 104
12345